Inpatient COVID-19 vaccination changes

February 8, 2022  //  FOUND IN: Updates & Resources

The Centers for Disease Control and Prevention (CDC) have updated their COVID-19 vaccine recommendations since the inpatient vaccination program launched at Michigan Medicine in September.

As a result, on Monday, Feb. 7, the order set for immunocompromised patients was updated. The order set now includes patients 5 years and older:

  • 5 years and older (if previously received Pfizer vaccine) who are moderately-severely immunocompromised (see below) quality for additional primary shot of Pfizer vaccine.
  • 18 years year and older (if previously received Moderna vaccine) who are moderately-severely immunocompromised (see below) quality for additional primary shot of Moderna vaccine.

The additional dose should be given at least 28 days after the second shot.

Based on CDC criteria, people are considered immunocompromised if they have:

  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress the immune response

Thank you for your flexibility and support of these changes.

RELATED STORIES